Skip to Content
  1. All products
  2. PT-141
  3. All products
Pricelist: Default Pricelist Pricelist
Pricelist: Default Pricelist Pricelist
PT-141

PT-141

Lyophilized Vial · Subcutaneous Store refrigerated at 2-8 C and protect from heat and light. 99% Purity · USP Grade
99% Purity
PHYSICIAN USE ONLY
$ 40.00 $ 40.00

Format
💉 vial
  • Strength
Add to cart
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days
Clinical Description

Libido enhancement, sexual arousal, sexual desire, performance improvement, sexual wellness for both men and women

PT-141 es un agonista del receptor de melanocortina que mejora la libido y la excitación sexual al actuar sobre el sistema nervioso en lugar del sistema vascular. A diferencia de los inhibidores de la PDE5 como Viagra, PT-141 funciona tanto para hombres como para mujeres al estimular las vías de respuesta sexual del cerebro. Se usa comúnmente para mejorar el deseo, el rendimiento y la excitación sexual sin afectar la presión arterial.

Clinical Indications
Performance and endurance protocolsCardiorespiratory output support plansTraining-recovery adaptation pathways
Recommended Stacking Protocols
✓
Oxytocin
Enhances emotional connection and post-arousal bonding
✓
GHK-Cu
Adds skin glow and recovery post-intimacy
✓
Selank
Reduces anxiety and supports relaxed mood

Mechanism of Action - Performance & Endurance Pathway

Targeted Signaling
Supports protocol objectives for PT-141.
Clinical Modulation
Allows dose and schedule adjustments by response.
Outcome Tracking
Pairs with clinician monitoring for iterative optimization.
Starting Dose
1-2mg as needed
Initiation phase for tolerance and baseline response.
Titration
Escalate by protocol
Maintenance Range
Maintain physician-directed target
Adjust based on objective outcomes and physician review.
Suggested Dosing Notes

Dosis típica:1-2 mg según sea necesario

Frecuencia:Úselo según sea necesario;no para uso diario

Momento:Inyectar 1-3 horas antes de la actividad sexual.

Period Dose Phase Clinical Notes
Typical Dose 1-2mg as needed maintenance Inject 1-3 hours before sexual activity. Start with lower doses to assess tolerance.
Weeks 3-6 Escalation phase escalation Increase per protocol if tolerated.
Week 7+ Maintenance phase maintenance Maintain target dose and reassess monthly.
Preparation Protocol
  1. PT-141 se suministra como polvo liofilizado.
  2. PT-141 debe reconstituirse con agua bacteriostatica antes de su uso.
  3. Añadir 2 mL de agua bacteriostatica al vial de 10 mg. Concentracion final: 5 mg/mL (50 mcg por unidad).
1
Inspect vial
Confirm vial integrity, lot, and expiration before use.
2
Aseptic reconstitution
Disinfect stopper and add bacteriostatic water slowly.
3
Gentle dissolution
Swirl gently until the solution is clear and homogeneous.
4
Prepare dose
Draw dose according to reconstitution conversion guidance.
Reconstitution & Dosing Guide
Standard 1 mL insulin syringe: 100 units = 1 mL

Total Peptide: 10 mg
BW: 2 mL
Concentration: 5mg/mL (50mcg per unit)
Dose Units to Draw Volume (mL) Approx. Supply
1mg 20 units - 10 doses (1+ weeks)
2mg 40 units - 5 doses (0.5 weeks)
Identity
  • Product Name: PT-141
  • Product Type: Vial | Subcutaneous Injection
  • Strength Options: 10 mg
  • Available Strengths: 10mg
Quality & Purity
  • Purity: >= 99%
  • Sterility: Aseptic handling required
  • Purity: 99%+
Storage & Handling
  • Storage: 2-8 C refrigerated
  • Handling: Avoid heat, shaking, and direct light
  • Storage: Refrigerate after reconstitution (2-8°C)
  • Syringe Tip: Inject subcutaneously with a 1mL insulin syringe

Timing: Timing:Inject 1-3hoursbeforesexual activity

Storage: Store refrigerated at 2-8 C and protect from heat and light.

Frequency: Frequency:Useasneeded;not fordailyuse

Cycle: Cycle length and cadence are clinician-defined per patient profile.

Injection Sites: Rotate approved injection sites to reduce local irritation risk.